Cancer Immunotherapy Pilot Program
The United States Patent and Trademark Office (USPTO or Office) is implementing a pilot program to provide for earlier review of patent applications pertaining to cancer immunotherapy ("Cancer Immunotherapy Pilot Program" or "Pilot Program") in support of the White House national $1 billion initiative to achieve ten years' worth of cancer research in the next five years ("National Cancer Moonshot"). The USPTO will advance applications containing a claim(s) to a method of treating a cancer using immunotherapy out of turn for examination if the applicant files a grantable petition to make special under the Pilot Program. The objective of the Pilot Program is to complete the examination of the application within twelve months of special status being granted. Under the Cancer Immunotherapy Pilot Program, an application will be advanced out of turn for examination without meeting all of the current requirements of the accelerated examination program (e.g., the requirement for an examination support document) or the Prioritized Examination (Track I) program. This notice outlines the conditions, eligibility requirements, and guidelines of the Pilot Program.
- Task
- Read the news
- Patent or trademark
- both
- Legacy system
- —
- Current entry point
- www.federalregister.gov/documents/2016/06/29/2016-15533/cancer-immunotherapy-pilot-program (permanent link in the Federal Register, verified 2026-09-30)
- Legacy system and where it moved
- No legacy system name mention in title or summary )
- Fee
- Fee mentioned in title or summary (Confirmed in the document text)
- What you need (account or API key)
- No account or key mention in title or summary )
- Published
- 2016-06-29
- Document type
- Notice
- Source
- USPTO documents published in the Federal Register (Federal Register API)(retrieved 2026-10-06)
Everything in the same category
Read the news (all 1988) · both (all 2333)
Related entry points
- Cancer Moonshot Expedited Examination Pilot Program
- COVID-19 Prioritized Examination Pilot Program
- Extension of the Cancer Immunotherapy Pilot Program and Request for Comments
- Extension of the Cancer Immunotherapy Pilot Program
- Pilot Program for Green Technologies Including Greenhouse Gas Reduction
- Changes to Practice for Petitions in Patent Applications To Make Special and for Accelerated Examination
- Semiconductor Technology Pilot Program
- Expansion and Extension of the Climate Change Mitigation Pilot Program
- Extension of the Cancer Immunotherapy Pilot Program
- Streamlined Claim Set Pilot Program
- Changes To Implement the Prioritized Examination Track (Track I) of the Enhanced Examination Timing Control Procedures
- Extension of the Cancer Immunotherapy Pilot Program
- Extension of the Cancer Immunotherapy Pilot Program
- Glossary Pilot Program
- Sunset of the Patent Application Backlog Reduction Stimulus Plan and a Limited Extension of the Green Technology Pilot Program
- Enhanced Examination Timing Control Initiative; Notice of Public Meeting